Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...
Delhi University has initiated the admission process for one-year postgraduate (PG) courses for the 2026-27 academic session.
Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results